Why the study?
Does mexiletine reduce transmural dispersion of repolarization and prevent torsade de pointes in canine models of LQT2 and LQT3?
Population
Arterially perfused wedge of canine left ventricle mimicking LQT2 (using d-sotalol) and LQT3 (using ATX-II)
Comparison
Mexiletine (2 to 20 micromol/L) vs Baseline conditions (d-sotalol or ATX-II alone)
Design
Preclinical
Authors
Loading...
May support human LQT2/LQT3 trials; leaves open clinical efficacy and safety.
Does mexiletine reduce transmural dispersion of repolarization and prevent torsade de pointes in canine models of LQT2 and LQT3?
Mexiletine effectively reduces transmural dispersion of repolarization and prevents torsade de pointes in experimental models of both LQT2 and LQT3, suggesting potential therapeutic value beyond LQT3.
Shimizu et al. (1997) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: